AVTR
Avantor, Inc.11.20
-0.08-0.71%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
7.64BP/E (TTM)
-Basic EPS (TTM)
-0.13Dividend Yield
0%Recent Filings
8-K
10-Q
8-K
8-K
Avantor chairman steps down
Avantor, Inc. announced on October 10, 2025, that Jonathan Peacock will step down as chairman and board member on December 31, 2025, with no disagreements on company matters. Current board member Gregory L. Summe will assume the chairman role starting January 1, 2026. This leadership transition ensures continuity at the top. Smooth handover.
8-K
Avantor refinances debt, boosts liquidity
Avantor bolstered its liquidity on October 9, 2025, by amending its credit agreement to secure $1.4 billion in revolving commitments maturing in 2030, a €400 million Euro Term A loan due 2030, and a €550 million Euro Term B-6 loan due 2032, while terminating its $300 million A/R facility after repaying $208 million outstanding. Proceeds refinanced existing debt, including the full €650 million redemption of 2.625% Senior Notes completed by October 10. This extends maturities and frees up operational funding. Yet covenants limit flexibility amid market shifts.
IPO
Employees
Sector
Industry
A
Agilent Technologies, Inc.
139.19-1.41
ATR
AptarGroup, Inc.
122.83+0.50
ATRC
AtriCure, Inc.
41.08+0.04
AVNT
Avient Corporation
30.50+0.02
AZTA
Azenta, Inc.
34.31-0.77
BDX
Becton, Dickinson and Company
196.39-3.70
BIO
Bio-Rad Laboratories, Inc.
302.02-5.90
RSCF
Reflect Scientific, Inc.
0.05+0.00
SOAGY
Sartorius AG
56.43-0.16
WST
West Pharmaceutical Services, I
266.44-5.42